Ken Tanaka
Jikei University School of Medicine
12 Papers
64 Citations
Ken Tanaka is an academic researcher from Jikei University School of Medicine. The author has contributed to research in topics: Cancer & Hepatic stellate cell. The author has an hindex of 9, co-authored 12 publications.
Chat about Author
Papers
The C-reactive protein/albumin ratio, a novel inflammation-based prognostic score, predicts outcomes in patients with hepatocellular carcinoma.
Akiyoshi Kinoshita,Hiroshi Onoda,Nami Imai,Akira Iwaku,Mutumi Oishi,Ken Tanaka,Nao Fushiya,Kazuhiko Koike,Hirokazu Nishino,Masato Matsushima +9 more
TL;DR: The CRP/Alb ratio might be an independent prognostic marker in patients with HCC, and may have comparable prognostic ability to other established inflammation-based prognostic scores.
401
Transplantation of Liver Organoids in the Omentum and Kidney
Ryota Saito,Yuji Ishii,Ryusuke Ito,Keisuke Nagatsuma,Ken Tanaka,Masaya Saito,Haruka Maehashi,Hideki Nomoto,Kiyoshi Ohkawa,Hiroshi Mano,Mamoru Aizawa,Hiroshi Hano,Katsuhiko Yanaga,Tomokazu Matsuura +13 more
TL;DR: The results suggested that the functions of liver organoids differed depending on the transplanted site in the recipient animals.
31
The functional interrelationship between gap junctions and fenestrae in endothelial cells of the liver organoid.
Masaya Saito,Tomokazu Matsuura,Keisuke Nagatsuma,Ken Tanaka,Haruka Maehashi,Keiko Shimizu,Yoshiaki Hataba,Fumitaka Kato,Isao Kashimori,Hisao Tajiri,Filip Braet +10 more
TL;DR: Examination of the possible relationship between functional intact gap junctional intercellular communication (GJIC) and fenestrae dynamics in M1-SEC cells revealed that oleamide affected the integrity of cell-to-cell contacts predominantly in FLC-5 hepatocytes.
23
Quercetin Inhibits the Action of 12-O-Tetradecanoylphorbol-13-Acetate, a Tumor Promoter
TL;DR: Quercetin inhibited the increased incorporation of inorganic phosphate into phospholipids of human embryo fibroblasts induced by 12-O-tetradecanoylphorbol-13-acetate (TPA), a potent tumor promoter, suggesting that quercet in may have antitumor promoter activity.
20
The Addition of C-Reactive Protein to Validated Staging Systems Improves Their Prognostic Ability in Patients with Hepatocellular Carcinoma
Akiyoshi Kinoshita,Hiroshi Onoda,Nami Imai,Akira Iwaku,Mutumi Oishi,Ken Tanaka,Nao Fushiya,Kazuhiko Koike,Hirokazu Nishino,Masato Matsushima,Hisao Tajiri +10 more
TL;DR: It is demonstrated that an elevated serumCRP level is independently associated with a poor prognosis in HCC patients, and the addition of the CRP level to the validated staging systems could improve the prognostic ability of each staging system.
17